Market closed
Tiziana Life Sciences Ltd./$TLSA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Ticker
$TLSA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
9
Website
TLSA Metrics
BasicAdvanced
$140M
-
-$0.13
0.15
-
Price and volume
Market cap
$140M
Beta
0.15
52-week high
$1.91
52-week low
$0.73
Average daily volume
350K
Financial strength
Current ratio
0.854
Quick ratio
0.815
Long term debt to equity
1.995
Total debt to equity
9.65
Interest coverage (TTM)
-3,159.80%
Management effectiveness
Return on assets (TTM)
-69.58%
Return on equity (TTM)
-181.23%
Valuation
Price to book
70.71
Price to tangible book (TTM)
70.71
Price to free cash flow (TTM)
-33.595
Growth
Earnings per share change (TTM)
-29.05%
3-year earnings per share growth (CAGR)
-38.82%
TLSA News
AllArticlesVideos
Tiziana Life Sciences announces patient dosing in Phase 2 MS trial at University of Massachusetts
Proactive Investors·2 weeks ago
Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial
GlobeNewsWire·2 weeks ago
Tiziana Life Sciences begins patient dosing in Phase 2 MS trial at Johns Hopkins
Proactive Investors·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Tiziana Life Sciences Ltd. stock?
Tiziana Life Sciences Ltd. (TLSA) has a market cap of $140M as of May 04, 2025.
What is the P/E ratio for Tiziana Life Sciences Ltd. stock?
The price to earnings (P/E) ratio for Tiziana Life Sciences Ltd. (TLSA) stock is 0 as of May 04, 2025.
Does Tiziana Life Sciences Ltd. stock pay dividends?
No, Tiziana Life Sciences Ltd. (TLSA) stock does not pay dividends to its shareholders as of May 04, 2025.
When is the next Tiziana Life Sciences Ltd. dividend payment date?
Tiziana Life Sciences Ltd. (TLSA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tiziana Life Sciences Ltd.?
Tiziana Life Sciences Ltd. (TLSA) has a beta rating of 0.15. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.